Detail akcie Biotika online

Business Summary: Biotika as is a Slovakia-based joint stock company that specializes in biotechnology and production of pharmaceutical. The Company's activities are grouped into three main areas: biotechnological production of the substances of penicillin, chlorotetracycline and dextrans; production of final drug-forms for both human and veterinary use, including: penicillin and cephalosporin preparations, hormonal preparations, vitamin preparations; as well as production of premixes containing nutrition additives and medicated nutritive preparations. As of December 31, 2011, the Company operated two wholly owned subsidiaries, COV as Slovenska Lupca and Biotkika KLF as Slovenska Lupca.
Financial Summary: BRIEF: For the six months ended 30 June 2024, Biotika as revenues decreased 36% to EUR5.9M. Net loss totaled EUR901K vs. income of EUR718K. Revenues reflect Substances segment decrease of 40% to EUR4.4M, United States segment decrease of 95% to EUR39K, India segment decrease of 26% to EUR772K. Net loss reflects Other Operating Income decrease of 97% to EUR18K (income), Wages/Salaries increase of 14% to EUR2M (expense).